AFP and hepatocellular carcinoma: Regarding the molecular features of high-risk and low-risk groups, we observed that elevated risk scores were predominantly observed in HCC patients with age<60 years, advanced TNM stage, poor pathological grade, larger tumor size or AFP>=400 ng/ml.